|
N=13,389 |
N=3,660 |
N=2,292 |
N=3,019 |
|
Recipient Characteristics |
|
|
|
|
|
Age (years) |
57 (48-64) |
55 (43-62) |
53 (41-61) |
59 (50-65) |
<0.001 |
Race |
|
|
|
|
|
White |
9,061 (68.0%) |
2,261 (62.2%) |
1,352 (59.4%) |
1,999
(66.6%) |
<0.001 |
Black |
2,748 (20.6%) |
940 (25.9%) |
674 (29.6%) |
444 (14.8%) |
|
Hispanic |
1,026 (7.7%) |
298 (8.2%) |
178 (7.8%) |
345 (11.5%) |
|
Asian |
400 (3.0%) |
112 (3.1%) |
61 (2.7%) |
199 (6.6%) |
|
Other |
84 (0.6%) |
22 (0.6%) |
13 (0.6%) |
16 (0.5%) |
|
BMI (kg/m2) |
27.99 (4.60) |
26.49 (5.29) |
27.28
(5.34) |
26.38 (4.51) |
<0.001 |
Heart Failure Etiology |
|
|
|
|
|
Non-Ischemic |
6,609 (49.4%) |
2,299 (63.0%) |
1,477 (64.6%) |
1,314
(43.6%) |
<0.001 |
Ischemic |
5,252 (39.3%) |
656 (18.0%) |
406 (17.8%) |
1,329 (44.1%) |
|
Congenital |
315 (2.4%) |
161 (4.4%) |
108 (4.7%) |
75 (2.5%) |
|
Restrictive |
418 (3.1%) |
168 (4.6%) |
84 (3.7%) |
125 (4.1%) |
|
Valvular |
159 (1.2%) |
64 (1.8%) |
36 (1.6%) |
36 (1.2%) |
|
Hypertrophic |
264 (2.0%) |
178 (4.9%) |
96 (4.2%) |
58 (1.9%) |
|
Other |
18 (0.1%) |
10 (0.3%) |
4 (0.2%) |
4 (0.1%) |
|
Diabetes Mellitus |
3,954 (29.6%) |
830 (22.8%) |
519 (22.7%) |
886
(29.4%) |
<0.001 |
Total Bilirubin (mg/dL) |
1.00 (1.67) |
0.85 (1.12) |
0.94 (1.65) |
1.00
(1.52) |
<0.001 |
Serum Creatinine (mg/dL) |
1.30 (0.59) |
1.08 (0.62) |
1.08 (0.55) |
1.26 (0.45) |
<0.001 |
Positive CMV Serology |
6,985 (52.2%) |
2,308 (63.1%) |
1,471 (64.2%) |
1,721 (57.0%) |
<0.001 |
Pretransplant Infection |
1,457 (11.2%) |
288 (8.1%) |
227 (10.2%) |
224 (7.6%) |
<0.001 |
Transfusion on Waitlist |
3,074 (23.7%) |
646 (18.2%) |
462 (20.8%) |
628 (21.3%) |
<0.001 |
Mechanical Ventilation |
160 (1.2%) |
41 (1.1%) |
15 (0.7%) |
53
(1.8%) |
0.003 |
Intensive Care Unit |
4,108 (30.7%) |
1,064 (29.1%) |
806 (35.2%) |
960 (31.8%) |
<0.001 |
Intravenous Inotropes |
4,371 (32.6%) |
1,472 (40.2%) |
908 (39.6%) |
1,206 (39.9%) |
<0.001 |
Intra-Aortic Balloon Pump |
1,320 (9.9%) |
325 (8.9%) |
235 (10.3%) |
288 (9.5%) |
0.25 |
Extracorporeal Membrane Oxygenation |
172 (1.3%) |
34 (0.9%) |
35
(1.5%) |
34 (1.1%) |
0.17 |
Donor Characteristics |
|
|
|
|
|
Donor Age (years) |
29 (22-39) |
34 (24-43) |
27 (21-37) |
35 (26-44) |
<0.001 |
Donor Race |
|
|
|
|
|
White |
8,487 (63.4%) |
2,506 (68.5%) |
1,315 (57.4%) |
2,069
(68.5%) |
<0.001 |
Black |
2,283 (17.1%) |
522 (14.3%) |
385 (16.8%) |
483 (16.0%) |
|
Asian |
2,204 (16.5%) |
496 (13.6%) |
512 (22.3%) |
374 (12.4%) |
|
Hispanic |
209 (1.6%) |
93 (2.5%) |
38 (1.7%) |
46 (1.5%) |
|
Other |
206 (1.5%) |
43 (1.2%) |
42 (1.8%) |
47 (1.6%) |
|
BMI (kg/m2) |
27.26 (5.43) |
27.98 (6.82) |
25.11
(4.84) |
30.07 (7.17) |
<0.001 |
Mechanism of Death |
|
|
|
|
|
Trauma |
7,387 (55.2%) |
1,029 (28.1%) |
1,318 (57.6%) |
841 (27.9%) |
<0.001 |
Cardiovascular |
2,061 (15.4%) |
1,123 (30.7%) |
339 (14.8%) |
973
(32.2%) |
|
Drug Overdose |
1,772 (13.2%) |
616 (16.8%) |
218 (9.5%) |
486
(16.1%) |
|
Other |
2,167 (16.2%) |
889 (24.3%) |
414 (18.1%) |
719 (23.8%) |
|
Diabetes Mellitus |
410 (3.1%) |
192 (5.3%) |
64 (2.8%) |
166 (5.5%) |
<0.001 |
Hypertension |
4,228 (31.9%) |
1,169 (32.3%) |
667 (29.4%) |
977
(32.6%) |
0.061 |
Serum Creatinine (mg/dL) |
1.60 (1.60) |
1.26 (1.33) |
1.46 (1.50) |
1.28 (1.29) |
<0.001 |
Donor LVEF <50% |
207 (1.5%) |
50 (1.4%) |
33 (1.4%) |
38
(1.3%) |
0.63 |
Positive CMV Serology |
7,755 (58.2%) |
2,482 (68.1%) |
1,406 (61.6%) |
2,024 (67.4%) |
<0.001 |
Hepatitis C Positive |
445 (3.3%) |
140 (3.8%) |
52 (2.3%) |
92
(3.0%) |
0.010 |
Transplant Characteristics |
|
|
|
|
|
Days Listed |
118 (31-335) |
75 (21-232) |
72 (19-237) |
77 (19-249) |
<0.001 |
Donor Distance from Recipient Hospital (nautical miles) |
86 (12-275) |
151 (22-352) |
92.5 (12-281.5) |
123 (22-334) |
<0.001 |
Cold Ischemic Time (hours) |
3.1 (2.4-3.8) |
3.2 (2.5-3.9) |
3.1
(2.3-3.8) |
3.3 (2.5-3.9) |
<0.001 |